Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Lue, N. F.
Right arrow Articles by Peng, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lue, N. F.
Right arrow Articles by Peng, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1997 Oxford University Press 4331-4337

Identification and characterization of a telomerase activity from Schizosaccharomyces pombe

Identification and characterization of a telomerase activity from Schizosaccharomyces pombe Neal F. Lue* and Yun Peng

Department of Microbiology, W. R. Hearst Microbiology Research Center, Cornell University Medical College, 1300 York Avenue, New York, NY 10021, USA

Received June 30, 1997; Revised and Accepted September 24, 1997

ABSTRACT

A telomerase-like primer extension activity has been detected in chromatographic fractions derived from Schizosaccharomyces pombe extracts. This primer extension activity acts preferentially on dG-rich oligodeoxynucleotides, is sensitive to RNase A pretreatment and requires all four deoxynucleotides for optimal polymerization. The extension products are also truncated by the inclusion of any one of the four dideoxynucleotides, consistent with the presence of all four bases in the S.pombe telomeric repeats. The intensity distribution of the extension products and the dideoxynucleotide termination pattern suggest that nucleotide addition is template directed, and that telomere-like sequences are added to the primers. In particular, the sequence d(CGGTTA), a variant of the S.pombe telomeric repeat, can be added directly by the in vitro activity. Partially purified S.pombe telomerase sediments as a 35S particle, suggesting that it exists in vivo as part of a large multi-protein complex.

INTRODUCTION

Telomeres are specialized nucleoprotein structures found at the ends of linear eukaryotic chromosomes. Telomeres confer stability to chromosomes by preventing nucleolytic degradation and recombination. They also function in chromosomal localization, nuclear architecture, and repression of nearby genes (1 ,2 ). The telomeric DNA of most organisms consists of simple tandem repeats that are rich in dG and dT residues on the 3' end-containing strand (3 ). This strand can be synthesized de novo by a ribonucleoprotein complex called telomerase (4 ,5 ), an enzyme that is critical to the maintenance of telomere length (6 ,7 ), and hence, function.

Telomerase activity was initially identified in Tetrahymena thermophila, a ciliated protozoa whose life cycle involves the formation of a large number of telomeres. The in vitro assay was based on telomerase's ability to extend telomere-like oligodeoxynucleotides in the presence of dGTP and dTTP (4 ). The enzyme was subsequently characterized as an unusual reverse transcriptase containing an integral RNA component, a small segment of which acts as the template for the synthesis of the dGT-rich strand of telomeric repeats (5 ). Multiple repeats can be added to the input primer following initial binding, despite the minimal number of repeat units in the RNA template, suggesting that the enzyme can undergo a translocation step during processive DNA synthesis, or that the enzyme can undergo multiple cycles of dissociation and reassociation with the primer. Telomerase can also cleave the input primer under certain conditions (8 ), a property that is shared by a number of DNA and RNA polymerases. Telomerase activity has been detected in a wide range of organisms including protozoa (9 ), yeast (10 -13 ), mouse (14 ), Xenopus (15 ) and human (16 ). The genes encoding the RNA component of the enzyme complex have also been cloned for most of the known telomerases, such as that of yeast and human (7 ,17 ). Most recently, some of the polypeptide components of telomerase were cloned. In particular, a protein named p123 in Euplotes aediculatus and a homologous protein encoded by EST2 in yeast were shown to be the catalytic components of the respective telomerases (18 ,19 ); these two polypeptides exhibit significant homology to other reverse transcriptases and mutations that alter Est2p residues that are conserved among reverse transcriptases abolish telomerase activity in vitro and telomerase function in vivo. In addition, two polypeptides, p80 and p95, that copurify with Tetrahymena telomerase have been cloned and been shown to interact with telomerase RNA and the DNA primer, respectively (20 ). Mouse and human homologues of p80 have also been identified, and been shown to associate with the respective telomerases (21 ,22 ). These recent developments should greatly facilitate structure-function analysis of telomerase.

Telomerase activity is easily detected in male and female reproductive tissues, and long telomeres are stably maintained in germ-line cells. In contrast, in most postnatal somatic cells, telomeric DNA is progressively lost with replicative aging and telomerase activity is undetectable in the majority of cases (23 ). This correlation suggests that telomerase is the major factor for counterbalancing the DNA loss anticipated from the `end replication' problem and that telomere shortening is one underlying mechanism for replicative aging. Such conjectures find strong support in yeast, where deletion of the telomerase RNA and a catalytic protein component leads to both telomere shortening, and eventually, a senescent phenotype (7 ,19 ). Furthermore, in tumor cells and postcrisis immortalized cell lines, telomere lengths are again stably maintained, and telomerase activity again becomes detectable in the majority of cases (24 ,25 ). However, telomerase-negative immortalized cells have also been observed, suggesting an alternative mechanism of telomere maintenance (26 ). Little is known about how telomerase activity is regulated.

As mentioned before, telomerase activity has been identified in both the RNA and a protein component cloned from the genetically tractable budding yeast Saccharomyces cerevisiae. However, for a number of reasons, the fission yeast Schizosaccharomyces pombe may be uniquely advantageous as a model system for the study of telomerase structure and function. First, while both yeasts are distantly related to higher eukaryotes, the genome organization and functional chromosomal elements of the fission yeast appear to share more characteristics with those of higher cells. Second, the cytological organization of the S.pombe nucleus is much better understood and much more easily investigated. Indeed, cytological studies in S.pombe have lead to the interesting conclusion that telomeres play a role in chromosomal movements during karyotomy and meiosis (26 ). Thus, cell biological questions regarding the spatial and temporal localization of telomerase components and their relationship to other nuclear structures may best be answered in the fission yeast. Finally, unlike telomeric sequences from most organisms, the S.pombe telomeric repeats are extremely irregular and conform to the following loose consensus: C A0-2 C0-1 G1-8 T1-3 A (27 ,28 ). The basis for this irregularity may constitute an important aspect of the mechanisms of nucleotide addition by telomerase. Study of S.pombe telomeres and telomerase has lagged far behind that of S.cerevisiae. However, a number of S.pombe telomeres have been cloned and sequenced, and proteins that specifically recognize S.pombe telomeric repeats have been identified and partially purified (29 ). Very recently, a telomere-binding protein in S.pombe (Taz1p) was cloned and shown to regulate telomere length and adjacent gene expression, and to be required for meiosis (30 ). In this paper we describe the identification and initial characterization of a primer extension activity that fulfills all of the available criteria for being the S.pombe telomerase.

MATERIALS AND METHODS

Yeast strains, media and buffers

The haploid S.pombe wild-type strain 972h- was used throughout. They were either grown in 3% glucose, 0.5% Yeast Extract or 3% glycerol, 1% glucose, 1% Bacto-Peptone, 2% Yeast Extract. Comparable results were obtained with either medium. The following protease inhibitors were included in all buffers: 1 mM phenylmethylsulfonyl fluoride, 2 mM benzamidine, 2 µg/ml pepstatin A and 1 µg/ml leupeptin. Buffer A contains 20 mM HEPES-NaOH, pH 7.6, 1 mM magnesium acetate, 20% glycerol, 1 mM DTT. Buffer A(500) etc. denotes buffer A plus the concentration of potassium acetate in mM specified by the number in parentheses.

Protein extracts and column fractionation

About 60 l of S.pombe cultures were grown to mid-log phase (~3 × 107 cells/ml), harvested, and washed once with ice-cold water. Cell pellets were resuspended with an equal volume of 3* Buffer A(0) (~200 ml of total suspension), adjusted with 5 M potassium acetate to a conductivity of ~50 mSi, mixed with ~150 ml of acid washed glass beads, transferred to a Biospec Bead-Beater chamber, and lysed with 15 20 s pulses. The Bead-Beater was turned off for 90 s following each pulse to allow for cooling of the lysate, which was achieved by surrounding the chamber with an ice/salt/glycerol bath that was kept at -10oC. Best results were obtained with the large Bead-Beater chamber. Cell lysates were collected and cleared by two successive centrifugations: first in a GSA rotor (Sorvall) at 8000 r.p.m. for 10 min, and then in a T-865 rotor (Sorvall) at 50 000 r.p.m. for 1 h. A typical extract has a protein concentration of ~15 mg/ml. While more prolonged bead-beating results in extracts of higher protein concentration, more inhibitors and/or contaminating activities are also released, making it difficult to detect telomerase activity.

Telomerase activity was partially purified by passage through a DEAE Sepharose (Fast-Flow, Pharmacia) and a Q-Sepharose (Fast-Flow, Pharmacia) column. Extracts were diluted with Buffer A(0) to a conductivity of ~40 mSi and loaded onto a DEAE-Sepharose column. The column was washed with 2 column vol of Buffer A(400) and the activity eluted with 5 column vol of a linear gradient from Buffer A(400) to A(1500). Peak fractions (eluting around 800 mM potassium acetate) were pooled, diluted with Buffer A(0) to a conductivity of ~50 mSi, and loaded onto a Q-Sepharose column. The column was washed with 2 column vol of Buffer A(500) and the activity eluted with 10 column vol of a gradient from Buffer A(500) to A(1500). Peak fractions (eluting around 1100 mM potassium acetate) together contained ~0.2% of the protein in the initial extract.

Glycerol gradient

Fractions from either the DEAE-Sepharose or Q-Sepharose column were adjusted to 10% glycerol by dilution and then concentrated several fold by passage through centricon-30 (Amicon). The resulting material was spun through a 10 ml glycerol gradient (20-50% glycerol, containing 20 mM HEPES-NaOH, pH 7.6, 1 mM magnesium acetate, 20% glycerol, 1 mM DTT and 300 mM potassium acetate) in an SW41 rotor at 30 000 r.p.m. for 20 h. Individual fractions were collected and assayed for telomerase activity. The positions of ribosomal particles and Blue Dextran2000 in a parallel gradient were used as molecular weight standards. Ribosome-containing extracts were prepared and ribosomal particles monitored according to published protocol (31 ).

Primer extension assays for S.pombe telomerase

A typical telomerase reaction was carried out in 25 µl containing the following: 50 mM HEPES-NaOH, pH 7.6, 4 mM magnesium glutamate, 30 mM potassium glutamate, 0.1 mM EDTA, 1 mM DTT, 5% glycerol (v/v), 50 µM dATP, 50 µM dCTP, 50 µM dTTP, 20 µCi of [[alpha]-32P]dGTP (3000 Ci/mmol), 5 µM of primer oligodeoxynucleotides, and ~5 µl of column fractions. Sometimes, a different radioactive nucleotide was used as label. In such cases, the concentrations of the labeled and unlabeled nucleotides are unchanged. For the RNase A inactivation experiments, 5 µl of telomerase was preincubated with 20 ng of RNase A at room temperature for 20 min before starting the reaction. As a further control, the fraction was sometimes treated simultaneously with 20 ng of RNase A and 2 U of an RNase inhibitor (Prime Inhibitor, 5 prime to 3 prime, Boulder, CO) before starting the assay. For the chain termination experiments, one of the cold deoxynucleotides is replaced by 50 µM of its dideoxynucleotide analogue. Following incubation at 30oC for 1.5 h, the reaction was stopped with 80 µl of 10 mM Tris-HCl, pH 8.0, 20 mM EDTA, 0.1 mg/ml RNase A, and incubated at room temperature for 10 min, and further digested with 100 µl of a solution containing 10 mM Tris-HCl, pH 8.0, 0.5% SDS and 0.3 mg/ml proteinase K. The digested reaction products were mixed with 750 µl of absolute ethanol and 100 µl of 7.5 M ammonium acetate containing 1 µg of yeast tRNA to precipitate the nucleic acids. The pellets were washed twice with 70% ethanol, resuspended in gel electrophoresis buffer containing tracking dyes, and analyzed on a 12 or 15% TBE-urea polyacrylamide gel. Dried gels were analyzed using a PhosphorImager system (Molecular Dynamics).

RESULTS

Identification of an S.pombe telomerase-like activity


Figure 1. Partial purification of S.pombe telomerase. Schizosaccharomyces pombe telomerase was partially purified over a DEAE-Sepharose and a Q-Sepharose column as described in Materials and Methods. (A) A plot of activity, protein concentration and conductivity against fraction number for a typical DEAE column. (B) A plot of activity and conductivity against fraction number for a typical Q column, along with the activity assay. Assays were performed using TEL4 as the primer and radioactive dGTP as label.


Figure 2. Primer utilization by S.pombe telomerase. Reactions were carried out using a panel of GT-rich oligonucleotides as primers and a DEAE fraction as source of telomerase. The sequences of the primers are displayed in Table 1. `PTEL' oligonucleotides have sequences that match the S.pombe telomeric repeats. Three sets of reactions (A, B and C) from three different gels are shown, each containing TEL4-mediated extension assays for comparison. All reactions use radioactive dGTP as the label. (A) The `primer + 2' and `primer + 6' products for the TEL4, TEL6 and TEL10 assays are indicated by large and small arrows, respectively. For the TEL13 assay, the `primer + 3' product is indicated by an arrow. The vertical bracket to the right of TEL4, TEL6 and TEL10 span products that are from ~67 to 600 nt in length. (B) The `primer + 2' and `primer + 6' products for the TEL4 and TEL6 assays are marked by arrows. (C) For size marker, the TEL4 and PTEL7 primers were labeled with radioactive cordycepin and terminal transferase and run alongside the reaction products.

Whole cell extracts from S.pombe are prepared by lysis with glass beads followed by ultracentrifugation. No telomerase-like activity can be detected in crude extracts using standard primer extension assays. However, fractions eluting from DEAE columns at ~800 mM potassium acetate are found to reproducibly support the extension of telomere-like primers (Figs 1 and 2 ). This primer extension activity can be further purified over a Q column (Fig. 1 B) and by glycerol gradient sedimentation (Fig. 5 ). The activity does not copurify with Tf2 proteins as determined by western blotting experiments, suggesting that we are not assaying for the reverse transcriptase associated with this retrotransposon, the only known retrotransposon in the 972h- strain (data not shown). Two classes of primer extension products are observed: one close in size to the input primer, the other up to a few hundred nucleotides in length (see for example, the TEL4 reaction products in Fig. 2 A). Both classes of products are primer dependent, and are abolished when the fraction is pre-treated with RNase A (Fig. 2 A, `TEL4' and `none' reactions). Simultaneous pre-treatment of the fraction with RNase A and an RNase inhibitor has no effect on the primer extension activity (data not shown). As will be described later, the results of sequence determination indicate that the short extension products are very likely due to telomerase. Some of the short products, which are shorter than the starting primer, probably arise as a result of the action of a telomerase-associated nuclease (8 ,11 ). Indeed, little degradation of the bulk of the input primer can be observed (data not shown), suggesting that the nuclease action is rather specific for the labeled products. The RNase-sensitive long extension products may be due to the processive action of telomerase, which has been observed for telomerase from many other sources (16 ,32 ). However, this interpretation has yet to be confirmed, for example, by sequencing the long products. Therefore, we confine the rest of our discussion to the short primer extension products.

Primer preference for S.pombe telomerase

Telomerases from many sources have been found to preferentially extend dGT-rich oligonucleotides, although the sequence requirements are not stringent. In particular, telomerase from one organism can often be found to efficiently elongate telomeric repeats from another organism. Furthermore, even non-telomeric primers can occasionally support reactions in vitro. In the case of the S.pombe activity, we have found that in addition to S.pombe primers (e.g. PTEL3, PTEL4, PTEL7, PTEL14 and PTEL15; Table 1 and Figs 2 C and 5 ), some S.cerevisiae primers (TEL4 and TEL6; Table 1 and Fig. 2 A) or a slight variant of S.cerevisiae primers (TEL13), which do not contain either dA or dC residues, can be efficiently extended. The presence of non-telomeric sequence at the 5' end of the primer has little effect on priming efficiency (comparing TEL4 with TEL10; Table 1 and Fig. 2 A). In contrast, including either a 6 or a 12 nt non-telomeric sequence at the 3' end of the primer abolishes the RNase-sensitive short extension products (comparing TEL4 with TEL8 and TEL9; Table 1 and Fig. 2 B).

Table 1 . Sequence of telomerase primers
Oligo Sequence
TEL4 TGTGGTGTGTGGGTGTG
TEL6 TGTGTGGGTGTG
TEL8 GTGTGTGGGTGTGGATCAT
TEL9 GTGTGTGGGTGTGCTACGCGATCAT
TEL10 CGGGATCCCGTGTGGTGTGTGGGTGTG
TEL13 TGTCTGGGTGTCTGGGT
PTEL3 GGTTACAGGTTACAGGTT
PTEL4 GGGTTACAGGTTACAGGT
PTEL7 TTACAGGGTTACAGGTTAC
PTEL13 TTACAGGGTTACAGGTTA
PTEL14 ACAGGGTTACAGGTTACG
PTEL15 CAGGGTTACAGGTTACGG

Patterns of extension by S.pombe telomerase

Close inspection of the distribution of the short products suggests that a specific sequence or sequences are added to the input primer. For example, there are clearly preferred pausing or termination sites, consistent with preferential dissociation of the enzyme at particular templating positions, which has been observed for many telomerases. A purely random addition of nucleotides would not be expected to generate such patterns. Furthermore, primers that have identical 3' ends yield very similar patterns of extension products. Reactions with TEL4, TEL6 and TEL10, which share 12 identical nucleotides at their 3' end, all result in a very strong band at the `primer +2' position, and a somewhat weaker band at the `primer + 6' position (Table 1 and Fig. 2 A; in Fig. 2 A, the large and small arrows to the right of the `TEL4', `TEL6' and `TEL10' reactions point to the `primer + 2' and `primer + 6' products, respectively). This pausing or termination property appears to be a conserved characteristic of all telomerases. In addition, the use of primers with different 3' ends results in different patterns of product distribution, consistent with the ability of telomerase to recognize the 3' end of primer through base-pairing. For example, The `TEL13' reaction yields a strong product at the `primer + 3' position, and the `PTEL7' reaction yields significant amount of products at the `primer + 1', `primer + 2' and `primer + 5' positions (Fig. 2 A and C).

Addition of a telomere-like sequence by S.pombe telomerase


Figure 3. The deoxynucleotide requirement for the S.pombe telomerase reaction. (A) Telomerase reactions were performed using TEL4 oligonucleotide as the primer and either [[alpha]-32P]dGTP or [[alpha]-32P]dTTP as the radioactive label. A fraction derived from DEAE column was used as the source of telomerase. In some reactions, one of the unlabeled deoxynucleotide was omitted (-) as indicated at the top of the figure. Primer labeled by radioactive cordycepin and terminal transferase are shown in lanes 1, 7 and 13 as size standards. Short horizontal lines to the left of some lanes are used to indicate the size of the products relative to primer, with the bottom-most line designating the `primer +1' product. (B) Telomerase reactions were performed using TEL4 oligonucleotide as the primer and [[alpha]-32P]dGTP as the radioactive label. A fraction derived from DEAE column was used as the source of telomerase. In some reactions, one of the unlabeled deoxynucleotides was replaced by its dideoxynucleotide analogue as indicated at the top of the figure (ddNTP). Significant bands are marked and their sizes indicated.


Figure 4. Termination of S.pombe telomerase-mediated primer extension by dideoxynucleotides. A fraction derived from DEAE column was used as the source of telomerase in these assays. Telomerase reactions were performed using TEL13 oligonucleotide as the primer, and either [[alpha]-32P]dATP or [[alpha]-32P]dTTP as the radioactive label. In some reactions, one of the unlabeled deoxynucleotides was replaced by its dideoxynucleotide analogue as indicated at the top of the figure (ddNTP). Significant bands are marked and their sizes indicated.

To obtain evidence that telomere-like sequences are added to the input primers, we analyzed reactions with the TEL4 primer in the absence of individual nucleotides. Because all four bases are present in the S.pombe telomeric repeat, omission of any one of the four is expected to affect primer elongation by telomerase from this organism. This is indeed the case (Fig. 3 A). As mentioned before, when radioactive dGTP was used in the reaction, two prominent bands at the `primer + 2' and `primer + 6' positions can be visualized (lane 2). This distribution is altered by the omission of any one of the other three nucleotides. Extension can be seen up to the `primer + 5' position in the absence of dATP (lane 4), suggesting that dA is first added at the `primer + 6' position. Similarly, extension can be seen up to the `primer + 3' position in the absence of dTTP (lane 6), suggesting that dT is first added at the `primer + 4' position. Omission of dCTP abolishes the signal almost completely (lane 5), suggesting that this nucleotide is added before dG. Overall, the addition of the following sequence to TEL4 is suggested by the termination patterns: d(C-G-C/G-T-C/G/T-A). This assignment is further supported by the results obtained when radioactive dTTP is employed. As shown in Figure 3 A, when radioactive dTTP is employed, the omission of dCTP or dGTP abolished the signal (lanes 11 and 12), while that of dATP yields signal up to the `primer + 5' position (lane 10).

Further confirmation on the particular sequence added to the TEL4 primer was obtained by the use of dideoxynucleotides (Fig. 3 B). Replacing dATP with ddATP results in loss of products longer than `primer + 6' (specifically the `primer + 7' product), confirming that dA is first added at this position. Similarly, replacing dTTP with ddTTP results in loss of products longer than `primer +4', indicating that dT is first added at this position. Finally, replacing dCTP with ddCTP results in the complete loss of signal, indicating that dC is incorporated first, before dG. In short, the data presented in Figure 3 A and B indicate that the first few nucleotides added to the input primer has the following sequence: d(C-G-C/G-T-C/G/T-A). Such a sequence can occur at random with a probability of only 1 in 700, suggesting that polymerization is not due to a non-sequence-specific reverse transcriptase. Furthermore, a version of this sequence, d(C-G-G-T-T-A), matches up well with the characterized S.pombe telomeric repeat (27 ,28 ), suggesting that the activity we have identified is indeed due to S.pombe telomerase, not some other RNA-dependent DNA polymerase.

Since telomerase is believed to interact with the 3' end of the DNA primer through base-pairing, altering the 3' end residue should result in a change in the sequence added. We therefore tested TEL13, which ends in d(G-G-G-T), in the same dideoxynucleotide termination assays (Fig. 4 ). Use of radioactive dATP or dTTP results in prominent labeling of the `primer + 2' band, suggesting that these two nucleotides are preferentially incorporated in the first two positions 3' to the input primer. Replacing dTTP with ddTTP in the [[alpha]-32P]dATP reaction essentially abolishes incorporation, indicating that dTTP is likely to be incorporated in the `primer + 1' position, before dATP (Fig. 4 , right panel). As expected, replacing dATP with ddATP in the [[alpha]-32P]dTTP reaction does not prevent incorporation at either the `primer + 1' or the `primer + 2' position (Fig. 4 , left panel), consistent with d(T-A) being the sequence of the first two nucleotides added. The `primer + 2' product thus has the sequence d(G-G-G-T-T-A) at its 3' end, very much conforming to the S.pombe telomere consensus. Because the primer extension activity has a strong tendency to pause or terminate at the `primer + 2' position, we could not determine with high confidence the identity of the nucleotides added subsequently.

Completion of a d(CGGTTA) repeat by S.pombe telomerase


Figure 5. Completion of the d(CGGTTA) repeat by S.pombe telomerase. Telomerase reactions were performed using the following primers: PTEL7 (A), PTEL14 (B), PTEL15 (C), PTEL4 (D), PTEL3 (E), PTEL13 (F). The name of the primer, the 3' last few nucleotides of each primer, and the nucleotides that are expected to be added by telomerase are indicated at the top of each panel. The radioactive labels used for individual reactions are also indicated at the top. Reactions were carried out with or without pretreatment of the fraction with RNase A as indicated at the bottom of each panel. The size of the products relative to starting primers are determined using primers labeled with radioactive cordycepin and terminal transferase (+1 standards) as shown in parts (A)-(E). To facilitate counting, the sizes of the products in some lanes are marked by short horizontal lines. The bottom-most lines indicate the `primer + 1' bands with each additional line indicating successively longer products.

Based on the termination patterns observed in the presence of dideoxynucleotides, we proposed that the sequence d(C-G-G-T-T-A) is likely to be added to the TEL4 primer, and that there is preferential pausing or termination of S.pombe telomerase following the addition of the dA residue. To gain further support for this assignment of sequence, we tested a series of primers that end in different permutations of this sequence for nucleotide utilization; as a consequence of preferential pausing or termination after the addition of dA residue, primers that end at progressively more 3' positions are expected to support the incorporation of fewer nucleotides. As shown in Figure 5 , our expectation is confirmed in its entirety. For example, the primer that ends in d(C-G) (PTEL14, Fig. 5 B) allows the incorporation of dG, dT and dA; the primer that ends in d(C-G-G) (PTEL15, Fig. 5 C) allows the incorporation of dT and dA; and the primer that ends in d(G-G-T-T) (PTEL3, Fig. 5 E) allows the incorporation of only dA. Furthermore, the positions at which radioactive nucleotides are first incorporated for the various primers are also as predicted. For example, for the primer that ends in d(C-G), the first radioactive dT is added at the `primer + 2' position (following the incorporation of dG first, as predicted, Fig. 5 B), whereas for the primer that ends in d(C-G-G), the first radioactive dT is added at the `primer + 1' position (Fig. 5 C). No significant deviations from the prediction are observed. Taken together, this set of results further confirm our earlier sequence assignment and indicate that the sequence d(C-G-G-T-T-A), a variant of the S.pombe telomeric repeats, can be added directly by the in vitro primer extension activity.

Identification of an S.pombe telomerase RNP particle in glycerol gradient


Figure 6. Schizosaccharomyces pombe telomerase sediments as a large RNA-protein complex through glycerol gradients. Active telomerase fractions from a DEAE column were pooled and concentrated several fold using centricon-30. The resulting fraction was spun through a glycerol gradient as described in Materials and Methods. Telomerase activity throughout the gradient was assayed using the TEL4 primer and using radioactive dGTP as label. Yeast ribosomes and Blue Dextran2000 spun in a parallel gradient were used as size standards and their location indicated at the top of the panel.

Telomerases from different sources have been found to have different apparent molecular weights. To obtain an estimate of the size of the S.pombe telomerase, we subjected both crude extracts and DEAE-Sepharose fractions to glycerol gradient sedimentation. The sedimentation was carried out in moderate salt concentration (300 mM potassium acetate) to minimize aggregation. Assays of the fractions indicate that telomerase in both preparations sedimented slightly ahead of Blue Dextran 2000, behaving as ~35S particles, which translate to ~1500 kDa in molecular weight (Fig. 6 , and data not shown). This is considerably larger than the reported sizes of ciliate telomerases, but only slightly larger than the mouse, human and S.cerevisiae enzymes (>1000, ~750 and 1000 kDa, respectively, refs 19 ,33 ).

DISCUSSION

We have described an RNA-dependent primer extension activity from S.pombe that fulfills all of the available criteria for being the S.pombe telomerase. All catalytic properties of this enzyme as reported here, including its primer preference, primer recognition and patterns of extension, have precedents in previously described telomerases.

If one assumes that all telomerases have fundamentally identical catalytic mechanisms and have similar catalytic components, then the large size of non-ciliate telomerases probably represent their association with other regulatory factors. The RNA component of non-ciliate telomerase, such as human (450 nt) and S.cerevisiae (1300 nt), albeit larger than that of ciliates, appears insufficient to account for the size difference. Because of the very different life cycles of ciliated protozoa, involving chromosomal fragmentation and the de novo formation of a large number of telomeres, factors that regulate telomerase activity in these organisms may be very different from those of others. Thus non-ciliate telomerase may contain a different set of regulatory factors than ciliate telomerase, leading to the observed size difference.

A particularly interesting trait of S.pombe telomeric repeat is its irregularity. As mentioned previously, only a very loose consensus sequence (C A0-2 C0-1 G1-8 T1-3 A) can be discerned. Although some sequence heterogeneity could arise as a result of recombination, this degree of irregularity may be due in part to the action of telomerase. However, in vitro, our S.pombe telomerase activity appears to synthesize preferentially one variant of this repeat, namely d(C-G-G-T-T-A). For example, a primer that ends in d(C-G-G) supports almost exclusively the addition of d(T-T-A) only. Despite the variability in the length of the dG tract in vivo, there is little evidence for the incorporation of more dG residues prior to that of d(T-T-A) in vitro. Similarly, there is little evidence for the incorporation of dA immediately following that of dC, despite the prevalence of such a dinucleotide unit in the S.pombe telomeres. These discrepancies suggest a number of intriguing possibility. First, there may be multiple telomerase activities in vivo, only one of which is detected by our current protocol. Second, the telomerase RNA may contain variants of the complements of d(C-G-G-T-T-A) repeats, but these variants are not utilized efficiently in vitro or not revealed by the primers employed thus far. Third, S.pombe telomerase in vivo may have a tendency to misalign with the template, giving rise to an irregular pattern.

Fourth, perhaps most interestingly, telomerase activity in vivo may be regulated or modified such that it becomes `sloppy'. One can imagine, for example, the sequence G1-8 being made as the enzyme repeatedly `slips' and uses the same `C' nucleotide in the template for base pairing and addition of dG residues. In this fashion, the S.pombe telomerase does not need to carry an RNA that contains all the possible combinations of complementary sequence in order to generate a characteristic S.pombe telomere. While such slippage reaction has been postulated to be responsible for runs of dinucleotides in some telomeres (11 ), repetitive addition of a single nucleotide has not been documented for any native telomerase. However, a Tetrahymena telomerase that carries a mutated RNA template has been found to incorporate stretches of dG residues that are longer than encoded by the template (34 ). More interesting still, the HIV reverse transcriptase has been found, under certain conditions, to use repeatedly the same templating base to make a significant stretch of homopolymer (35 ). Thus enzyme slippage may be a feature not only of telomerases, but of some reverse transcriptases as well. That a single telomerase RNA can support the synthesis of multiple variants of a repeat is apparently true for paramecium, as reported recently (36 ).

The possibility of enzyme slippage makes it impossible to ascertain the telomerase RNA template sequence from sequences of the reaction products. While it is tempting to speculate that the sequence r(T-A-A-C-C-G) is part of the S.pombe telomerase RNA, based on our investigation of nucleotide addition by the in vitro activity and the sequence of cloned S.pombe telomeres, such an interpretation cannot be confirmed without cloning the gene encoding S.pombe telomerase RNA. Identification of this RNA, coupled with detailed in vitro analysis of the activity, should lead to further insights on telomerase mechanisms.

ACKNOWLEDGEMENTS

We thank Dr Henry Levin for antibodies against Tf proteins, and Ken Berns for helpful comments on the manuscript.

REFERENCES

1 Blackburn,E.H. (1991) Nature 350, 569-573. MEDLINE Abstract

2 Blackburn,E.H. (1994) Cell 77, 621-623. MEDLINE Abstract

3 Zakian,V.A. (1989) Annu. Rev. Genet. 23, 579-604. MEDLINE Abstract

4 Greider,C.W. and Blackburn,E.H. (1985) Cell 43, 405-413. MEDLINE Abstract

5 Greider,C.W. and Blackburn,E.H. (1989) Nature 337, 331-337. MEDLINE Abstract

6 Yu,G.-L., Bradley,J.D., Attardi,L.D. and Blackburn,E.H. (1990) Nature 344, 126-132. MEDLINE Abstract

7 Singer,M.S. and Gottschling,D.E. (1994) Science 266, 404-409. MEDLINE Abstract

8 Collins,K. and Greider,C.W. (1993) Genes Dev. 7, 1364-1376. MEDLINE Abstract

9 Blackburn,E.H. (1992) Annu. Rev. Biochem. 61, 113-129. MEDLINE Abstract

10 Lin,J.-J. and Zakian,V. (1995) Cell 81, 1127-1135. MEDLINE Abstract

11 Cohn,M. and Blackburn,E.H. (1995) Science 269, 396-400. MEDLINE Abstract

12 Prescott,J. and Blackburn,E.H. (1997) Genes Dev. 11, 528-540. MEDLINE Abstract

13 Steiner,B.R., Hidaka,K. and Futcher,B. (1996) Proc. Natl. Acad. Sci. USA 93, 2817-2821. MEDLINE Abstract

14 Prowse,K.R., Avilion,A.A. and Greider,C.W. (1993) Proc. Natl. Acad. Sci. USA 90, 1493-1497. MEDLINE Abstract

15 Mantell,L.L. and Greider,C.W. (1994) EMBO J. 13, 3211-3213. MEDLINE Abstract

16 Morin,G. (1989) Cell 59, 521-529. MEDLINE Abstract

17 Feng,J., Funk,W.D., Wang,S.-S., Weinrich,S.L., Avillion,A.A., Chiu,C.-P., Adams,R.R., Chang,E., Allsopp,R.C., Yu,J., et al. (1995) Science 269, 1236-1241. MEDLINE Abstract

18 Lendvay,T.S., Morris,D.K., Sah,J., Balasubramanian,B. and Lundblad,V. (1996) Genetics 144, 1399-1412. MEDLINE Abstract

19 Lingner,J., Hughes,T.R., Shevchenko,A., Mann,M., Lundblad,V. and Cech,T.R. (1997) Science 276, 561-567. MEDLINE Abstract

20 Collins,K., Kobayashi,R. and Greider,C.W. (1995) Cell 81, 677-686. MEDLINE Abstract

21 Harrington,L., McPhail,T., Mar,V., Zhou,W., Oulton,R., Amgen EST Program, Bass,M.B., Arruda,I. and Robinson,M.O. (1997) Science 275, 973-977. MEDLINE Abstract

22 Nakayama,J.-I., Saito,M., Nakamura,H., Matsuura,A. and Ishikawa,F. (1997) Cell 88, 875-884. MEDLINE Abstract

23 Harley,C.B. and Villeponteau,B. (1995) Curr. Opin. Gen. Dev. 5, 249-255.

24 Kim,N.W., Piatyszek,M.A., Prowse,K.R., Harley,C.B., West,M.D., Ho,P.L.C., Coviello,G.M., Wright,W.E., Weinrich,S.L. and Shay,J.W. (1994) Science 266, 2011-2015. MEDLINE Abstract

25 Counter,C.M., Hirte,H.W., Bacchetti,S. and Harley,C.B. (1994) Proc. Natl. Acad. Sci. USA 91, 2900-2904. MEDLINE Abstract

26 Chikashige,Y., Ding,D.Q., Funabiki,H., Haraguchi,T., Mashiko,S., Yanagida,M. and Hiraoka,Y. (1994) Science 264, 270-273. MEDLINE Abstract

27 Sugawara,N.S. and Szostak,J.W. (1986) Yeast 2, 373.

28 Sugawara,N. (1989) Ph.D. Thesis, Harvard University.

29 Duffy,M. and Chambers,A. (1996) Nucleic Acids Res. 24, 1412-1419. MEDLINE Abstract

30 Cooper,J.P., Nimmo,E.R., Allshire,R.C. and Cech,T.R. (1997) Nature 385, 744-747. MEDLINE Abstract

31 Ripmaster,T.L., Vaughn,G.P. and Woolford,J.L.,Jr (1994) Proc. Natl. Acad. Sci. USA 89, 11131-11135.

32 Greider,C.W. (1991) Mol. Cell. Biol. 11, 4572-4580. MEDLINE Abstract

33 Autexier,C., Pruzan,C., Funk,W.D. and Greider,C.W. (1996) EMBO J. 15, 5928-5935. MEDLINE Abstract

34 Gilley,D., Lee,M.S. and Blackburn,E.H. (1995) Genes Dev. 9, 2214-2226. MEDLINE Abstract

35 Ricchetti,M. and Buc,H. (1996) Biochemistry 35, 14970-14983. MEDLINE Abstract

36 McCormick-Graham,M. and Romero,D.P. (1996) Mol. Cell. Biol. 16, 1871-1879


*To whom correspondence should be addressed. Tel: +1 212 746 6506; Fax: +1 212 746 8587; Email: nflue@mail.med.cornell.edu


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Genes Dev.Home page
M. Chang, M. Arneric, and J. Lingner
Telomerase repeat addition processivity is increased at critically short telomeres in a Tel1-dependent manner in Saccharomyces cerevisiae
Genes & Dev., October 1, 2007; 21(19): 2485 - 2494.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Trujillo, J. T. Bunch, and P. Baumann
Extended DNA Binding Site in Pot1 Broadens Sequence Specificity to Allow Recognition of Heterogeneous Fission Yeast Telomeres
J. Biol. Chem., March 11, 2005; 280(10): 9119 - 9128.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. P. Munoz and K. Collins
Biochemical properties of Trypanosoma cruzi telomerase
Nucleic Acids Res., September 30, 2004; 32(17): 5214 - 5222.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Huard and C. Autexier
Human telomerase catalyzes nucleolytic primer cleavage
Nucleic Acids Res., April 19, 2004; 32(7): 2171 - 2180.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. H. Underwood, R. P. Zinzen, and M. J. McEachern
Template Requirements for Telomerase Translocation in Kluyveromyces lactis
Mol. Cell. Biol., January 15, 2004; 24(2): 912 - 923.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Bosoy and N. F. Lue
Yeast telomerase is capable of limited repeat addition processivity
Nucleic Acids Res., January 2, 2004; 32(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
S. M. Singh, O. Steinberg-Neifach, I. S. Mian, and N. F. Lue
Analysis of Telomerase in Candida albicans: Potential Role in Telomere End Protection
Eukaryot. Cell, December 1, 2002; 1(6): 967 - 977.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Niu, J. Xia, and N. F. Lue
Characterization of the Interaction between the Nuclease and Reverse Transcriptase Activity of the Yeast Telomerase Complex
Mol. Cell. Biol., September 15, 2000; 20(18): 6806 - 6815.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
L. Magnenat, H. Tobler, and F. Muller
Developmentally Regulated Telomerase Activity Is Correlated with Chromosomal Healing during Chromatin Diminution in Ascaris suum
Mol. Cell. Biol., May 1, 1999; 19(5): 3457 - 3465.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
E. C. Greene and D. E. Shippen
Developmentally programmed assembly of higher order telomerase complexes with distinct biochemical and structural properties
Genes & Dev., September 15, 1998; 12(18): 2921 - 2931.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. H. Haering, T. M. Nakamura, P. Baumann, and T. R. Cech
Analysis of telomerase catalytic subunit mutants in vivo and in vitro in Schizosaccharomycespombe
PNAS, June 6, 2000; 97(12): 6367 - 6372.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Lue, N. F.
Right arrow Articles by Peng, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lue, N. F.
Right arrow Articles by Peng, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?